Rating scales in psychiatric disorders - why?


  • Bhuvaneswari Rajachandrasekar Department of Psychiatry, National Homoeopathy Research Institute in Mental Health, Kottayam, Kerala, India https://orcid.org/0000-0002-6259-7944
  • Sakthivel Vaiyapuri National Homoeopathy Research Institute in Mental Health, Kottayam, Kerala, India




Rating scales, Clinical research, Psychiatry, Outcome assessment


Clinical and research instruments are available for assessing patients with psychiatric illness along specific dimensions of symptoms, comorbidities, and other health outcomes. Rating scales in clinical practice and research standardize diagnosis and assessment. Here, we focus on rating scales for common psychiatric disorders like schizophrenia, obsessive-compulsive disorder, depression, anxiety disorder, and stress-related disorders. Structured observation is most commonly used with this tool. Here are a few tools with basic characteristics, such as clarity, relevance, variety, objectives, and uniqueness. Rating scales will be discussed in clinical and research settings and future directions in their use. People using scales for commercial purposes should check for access and availability since some scales are copyrighted. The more standardization can be achieved, the easier it will be to compare individuals or groups of individuals. We will be able to assess care quality and outcomes across settings.


American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM-5). 5th ed. Arlington, VA: American Psychiatric Association Publishing. 2013.

Sadock BJ, Sadock VA, Ruiz P. Kaplan & Sadock’s Synopsis of Psychiatry. Eleventh edition. Wolters Kluwer Private Limited New Delhi. 2018.

Opler MG, Perrin MC, Kleinhaus K, Malaspina D. Factors in the Etiology of Schizophrenia: Genes, Parental Age, and Environment. Primary psychiatry. 2008;15(6).

Flemenbaum A, Zimmermann RL. Inter-and intra-rater reliability of the Brief Psychiatric Rating Scale. Psychol Rep. 1973;33(3):783-92.

Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophrenia bulletin. 1987;13(2):261-76.

Haddock G, McCarron J, Tarrier N, Faragher EB. Scales to measure dimensions of hallucinations and delusions: the psychotic symptom rating scales (PSYRATS). Psychol Med. 1999;29(4):879-89.

Haro JM, Kamath SA, Ochoa SO, Novick D, Rele K, Fargas A, et al. The Clinical Global Impression–Schizophrenia scale: a simple instrument to measure the diversity of symptoms present in schizophrenia. Acta Psychiatrica Scandinavica. 2003;107:16-23.

Andreasen NC. Scale for the assessment of positive symptoms. Psychiatrie & Psychobiologie. 1984.

Andreasen NC. The Scale for the Assessment of Negative Symptoms (SANS): conceptual and theoretical foundations. Br J Psychiatry. 1989;155(S7):49-52.

Keefe RS, Poe M, Walker TM, Kang JW, Harvey PD. The Schizophrenia Cognition Rating Scale: an interview-based assessment and its relationship to cognition, real-world functioning, and functional capacity. Am J Psychiatry. 2006;163(3):426-32.

Kumari S, Malik M, Florival C, Manalai P, Sonje S. An assessment of five (PANSS, SAPS, SANS, NSA-16, CGI-SCH) commonly used symptoms rating scales in schizophrenia and comparison to newer scales (CAINS, BNSS). J Addiction Res Therapy. 2017;8(3).

Velligan DI, Alphs L, Lancaster S, Morlock R, Mintz J. Association between changes on the Negative Symptom Assessment scale (NSA-16) and measures of functional outcome in schizophrenia. Psychiatry Res. 2009;169(2):97-100.

Karow A, Naber D. Subjective well-being and quality of life under atypical antipsychotic treatment. Psychopharmacology. 2002;162:3-10.

Guy W, Ban TA, Wilson WH. The prevalence of abnormal involuntary movements among chronic schizophrenic. Int Clin Psychopharmacol. 1986;1(2):134-44.

Marcus M, Yasamy MT, van Ommeren MV, Chisholm D, Saxena S. Depression: A global public health concern. American Psychological Association. 2012.

Sajatovic M, Opler M, Junewicz A, Opler L. Rating Scales for Psychiatric Disorders. Med Basis Psychiatry. 2016;869-80.

Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23(1):56.

Frank E, Prien RF, Jarrett RB, Keller MB, Kupfer DJ, Lavori PW, et al. Conceptualization and rationale for consensus definitions of terms in major depressive disorder: remission, recovery, relapse, and recurrence. Arch Gen Psychiatry. 1991;48(9):851-5.

Beck AT, Ward C, Mendelson M, Mock J, Erbaugh JJ. Beck depression inventory (BDI). Arch Gen Psychiatry. 1961;4(6):561-71.

Beck AT, Steer RA, Brown GK. Beck depression inventory. New York: Harcourt Brace Jovanovich. 1987.

Rush AJ, Giles DE, Schlesser MA, Fulton CL, Weissenburger J, Burns C. The inventory for depressive symptomatology (IDS): preliminary findings. Psychiatry Res. 1986;18(1):65-87.

Rush AJ, Gullion CM, Basco MR, Jarrett RB, Trivedi MH. The inventory of depressive symptomatology (IDS): psychometric properties. Psychol Med. 1996;26(3):477-86.

Montgomery SA, Åsberg MA. A new depression scale designed to be sensitive to change. Br J Psychiatry. 1979;134(4):382-9.

Chamorro L, Luque A, Lobo A. Validation of the Spanish versions of the Montgomery-Asberg depression and Hamilton Anxiety rating scales. Medicina Clínica. 2002;118(13):493-9.

Zung WW. A self-rating depression scale. Arch Gen Psychiatry. 1965;12(1):63-70.

White J, White K, Razani J. Effects of endogenicity and severity on consistency of standard depression rating scales. J Clin Psychiatry. 1984;45(6):260-1.

NIMH. Major Depressive Disorder Among Adults. Available at: http://www.nimh.nih.gov/statistics/1mdd_adult.shtml. Accessed on 13 October 2023.

Kroenke K, Spitzer RL, Williams JB. The PHQ‐9: validity of a brief depression severity measure. J Gen Int Med. 2001;16(9):606-13.

Snaith RP. The hospital anxiety and depression scale. Health and quality of life outcomes. 2003;1(1):1-4.

Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatrica Scandinavica. 1983;67(6):361-70.

Parkitny L, McAuley J. The depression anxiety stress scale (DASS). J Physiotherapy. 2010;56(3):204.

Radloff LS. The CES-D scale: A self-report depression scale for research in the general population. Appl Psychol Measurement. 1977;1(3):385-401.

Weissman MM, Sholomskas D, Pottenger M, Prusoff BA, Locke BZ. Assessing depressive symptoms in five psychiatric populations: a validation study. Am J Epidemiol. 1977;106(3):203-14.

Meyer TJ, Miller ML, Metzger RL, Borkovec TD. Development and validation of the penn state worry questionnaire. Behav Res Therapy. 1990;28(6):487-95.

Stein DJ. Comorbidity in generalized anxiety disorder: impact and implications. J Clin Psychiatry. 2001;62:29-36.

Allgulander C. Generalized anxiety disorder: a review of recent findings. J Exp Clin Med. 2012;4(2):88-91.

Beck AT, Epstein N, Brown G, Steer RA. An inventory for measuring clinical anxiety: psychometric properties. J Consult Clin Psychol. 1988;56(6):893-7.

Steer RA, Rissmiller DJ, Beck AT. Use of the Beck Depression Inventory-II with depressed geriatric inpatients. Behav Res Therapy. 2000;38(3):311-8.

Hamilton M. Diagnosis and rating of anxiety. Br J Psychiatry. 1969;3:76-9.

Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol. 1959;32:50-5.

Reiss S, Peterson RA, Gursky DM, McNally RJ. Anxiety sensitivity, anxiety frequency and the prediction of fearfulness. Behav Res Therapy. 1986;24(1):1-8.

Peterson RA, Reiss S. Anxiety sensitivity index revised test manual. IDS Publications. 1993.

Liebowitz MR. Social phobia. Mod Probl Pharmacopsychiatry. 1987;22:141-73.

Shahid A, Wilkinson K, Marcu S, Shapiro CM, editors. STOP, THAT and one hundred other sleep scales. Springer Science & Business Media. 2012.

Picardi A. Rating scales in bipolar disorder. Curr Opin Psychiatry. 2009;22(1):42-9.

Rush Jr AJ, First MB, Blacker D, editors. Handbook of psychiatric measures. American Psychiatric Pub. 2009.

Tohen M, Bowden C, Nierenberg AA, Geddes J, editors. Clinical trial design challenges in mood disorders. Academic Press. 2015.

Young RC, Biggs JT, Ziegler VE, Meyer DA. A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry. 1978;133(5):429-35.

Endicott J, Spitzer RL. A diagnostic interview: the schedule for affective disorders and schizophrenia. Arch Gen Psychiatry. 1978;35(7):837-44.

Berk M, Malhi GS, Cahill C, Carman AC, Hadzi‐Pavlovic D, Hawkins MT, et al. The Bipolar Depression Rating Scale (BDRS): its development, validation and utility. Bipolar Disorders. 2007;9(6):571-9.

Berk M, Malhi GS, Mitchell PB, Cahill CM, Carman AC, Hadzi‐Pavlovic D, et al. Scale matters: the need for a Bipolar Depression Rating Scale (BDRS). Acta Psychiatrica Scandinavica. 2004;110:39-45.

Hirschfeld RM. The Mood Disorder Questionnaire: A Simple, Patient-Rated Screening Instrument for Bipolar Disorder. Prim Care Companion J Clin Psychiatry. 2002;4(1):9-11.

Gonzalez JM, Bowden CL, Katz MM, Thompson P, Singh V, Prihoda TJ, et al. Development of the Bipolar Inventory of Symptoms Scale: concurrent validity, discriminant validity and retest reliability. Int J Methods Psychiatric Res. 2008;17(4):198-209.

Thompson PM, Gonzalez JM, Singh V, Schoolfield JD, Katz MM, Bowden CL. Principal domains of behavioral psychopathology identified by the Bipolar Inventory of Signs and Symptoms Scale (BISS). Psychiatry Res. 2010;175(3):221-6.

Ghaemi SN, Miller CJ, Berv DA, Klugman J, Rosenquist KJ, Pies RW. Sensitivity and specificity of a new bipolar spectrum diagnostic scale. J Affective Disord. 2005;84(2-3):273-7.

Goodman WK, Price LH, Rasmussen SA, Mazure C, Delgado P, Heninger GR, et al. The Yale-Brown Obsessive Compulsive Scale. II. Validity. Arch Gen Psychiatry. 1989;46(11):1012-6.

Goodman WK, Price LH, Rasmussen SA, Mazure C, Fleischmann RL, Hill CL, et al. The Yale-Brown obsessive compulsive scale: I. Development, use, and reliability. Arch Gen Psychiatry. 1989;46(11):1006-11.

Tolin DF, Abramowitz JS, Diefenbach GJ. Defining response in clinical trials for obsessive-compulsive disorder: a signal detection analysis of the Yale-Brown obsessive compulsive scale. J Clin Psychiatry. 2005;66(12):1549-57.

Turner SM, Beidel DC, Dancu CV, Stanley MA. An empirically derived inventory to measure social fears and anxiety: the Social Phobia and Anxiety Inventory. Psychol Assessment J Consult Clin Psychol. 1989;1(1):35.

Mattick RP, Clarke JC. Development and validation of measures of social phobia scrutiny fear and social interaction anxiety. Behav Res Therapy. 1998;36(4):455-70.

Blake DD, Weathers FW, Nagy LM, Kaloupek DG, Gusman FD, Charney DS, et al. The development of a Clinician-Administered PTSD Scale. J Trauma Stress. 1995;8(1):75-90.




How to Cite

Rajachandrasekar, B., & Vaiyapuri, S. (2023). Rating scales in psychiatric disorders - why?. International Journal Of Community Medicine And Public Health, 10(11), 4502–4511. https://doi.org/10.18203/2394-6040.ijcmph20233502



Review Articles